AI assistant
INNOVATIVE SOLUTIONS & SUPPORT INC — Director's Dealing 2025
Apr 3, 2025
33638_dirs_2025-04-02_12a45311-98bc-4738-8541-a0d3178c430f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC)
CIK: 0000836690
Period of Report: 2025-02-18
Reporting Person: Askarpour Shahram (CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-18 | Restricted Stock Units | A | 37835 | $0.00 | Acquired | 370317 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | Non-Qualified Stock Option (Right to Buy) | $9.88 | A | 72062 | Acquired | 2035-02-18 | Common Stock (72062) | Direct |
Footnotes
F1: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of RSUs is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. Each RSU represents the right to receive one share of Common Stock, subject to adjustment as provided in the Award Agreement. The RSUs are scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person.
F2: The non-qualified stock option was granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of shares of Common Stock underlying the option is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. The option is scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person. The option becomes exercisable, if at all, if the price of the Company's common stock on the Nasdaq Stock Market is equal to or greater than $9.8785 for 20 consecutive trading days during the vesting period of the option.